Filing Details
- Accession Number:
- 0001348362-24-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 14:03:28
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-03 14:03:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1348362 | Lexaria Bioscience Corp. | LEXX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1271244 | Richard Christopher | C/O Lucid, Inc. 50 Methodist Hill Dr, Suite 1000 Rochester NY 14623 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2024-12-02 | 22,828 | $2.24 | 22,828 | No | 4 | P | Direct | |
Common Shares | Acquisiton | 2024-12-03 | 27,172 | $2.47 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Stock Options | $3.92 | 2025-02-28 | 2029-08-31 | 200,000 | 200,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2029-08-31 | 200,000 | 200,000 | Direct |
Footnotes
- Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026